Alnylam has obesity gene target in its sights
Cambridge, Massachusetts based, Alnylam Pharmaceuticals, along with collaborators, has identified mutations in the INHBE gene linked with protection against abdominal obesity.
Archives for July 28, 2022
Increased demand for aseptic filling sees Cytiva boost manufacturing capacity in Vancouver
This week saw Cytiva open a new 126 200 ft2 (11,724 m2) site in the greater Vancouver area, Canada.
Samsung Biologics on track to open ‘super plant’ in October
Construction of Samsung Biologics’ Plant 4 is on schedule with operations set to start in October, the company confirmed in its Q2 results this morning.
Bavarian Nordic gets US and EU approval for Denmark fill finish vaccine facility
Bavarian Nordic A/S has received approvals from the US and EU regulatory authorities to manufacture its Jynneos/Imvanex smallpox and monkeypox vaccine at its fill and finish facility in Denmark.